peptide therapeutics – Talk Bio

Actionable Insights Powered by AI

MBX Biosciences Enters IPO Queue Amid End-of-Summer Rush

8 months ago talkbio0Tagged Biosciences, IPO, MBX, Nasdaq, peptide therapeutics, public entity

MBX Biosciences, IPO, NASDAQ, peptide therapeutics, biotech, public offering

MBX Secures $63.5M in Funding Ahead of Clinical Readouts

9 months ago talkbio0Tagged Clinical Readouts, Engineer, Hypoparathyroidism, MBX, peptide therapeutics, Phase 2 Clinical Trials

MBX, clinical readouts, funding, engineered peptide therapeutics, hypoparathyroidism, Phase II trial